A Massachusetts Tax Change Just Cost One Company $100,000 It Didn't Expect

A small Massachusetts software company called Trivium Interactive did everything by the book. When Congress passed the One Big Beautiful Bill Act in July 2025 and restored full, immediate expensing of research and development costs, the company relied on that change the way it was designed to be relied on — deducting its R&D spending right away instead of stretching it out over years. Then the state tax bill arrived. Trivium now owes Massachusetts more than $100,000 it didn't budget for, because the state never agreed to follow the federal rule that made the deduction possible in the first place.

If your business does any research and development in Massachusetts — software, biotech, medical devices, defense, architecture, or engineering — this is worth reading closely, because the same surprise is landing on companies across the state, and the fix Beacon Hill passed only delays the problem instead of solving it.

What Actually Changed

Before the OBBBA, businesses that spent money on research and development had to amortize those costs — deduct them gradually over five years — under rules that had been in place since the 2017 Tax Cuts and Jobs Act. The OBBBA reversed that, letting businesses immediately expense R&D costs again on their federal returns, retroactive to 2022 for many companies. For research-heavy small and midsize businesses, that was a significant cash-flow win: instead of waiting five years to fully deduct a big R&D investment, you could take the whole deduction the year you spent the money.

Massachusetts, however, "decoupled" from that federal change. In plain terms: the state simply declined to update its own tax code to match the new federal treatment. So while your federal return lets you expense R&D costs immediately, your Massachusetts state return still requires you to amortize those same costs over five years. The result is that your state taxable income ends up higher than your federal taxable income for the same spending — sometimes dramatically higher — even though you didn't actually make any more money.

Why the Bill Is Landing Now

The mismatch wasn't just theoretical. Because the federal change was retroactive, many Massachusetts businesses went back and amended their 2022 through 2024 returns to claim the immediate federal deduction, assuming — reasonably — that the state would eventually follow suit or that the difference would be a paperwork issue rather than a cash one. It wasn't. Massachusetts gave businesses until July 6, 2026 to retroactively amend those prior returns, but companies that already filed amended returns assuming state conformity are now being told to re-file using the old five-year write-off schedule for state purposes instead.

That's exactly the trap Trivium Interactive fell into, according to reporting on the issue: the company acted in good faith on the federal change, then found itself facing an unexpected state tax liability on income it had already planned around as being sheltered by the deduction. For a small or midsize company, a six-figure surprise tax bill isn't a rounding error — it's a cash-flow emergency that can force hard choices about payroll, hiring, or planned investment.

How Much This Is Actually Costing

The scale of the mismatch shows up in the state's own numbers. Massachusetts estimated that fully conforming to the federal R&D expensing change — meaning letting businesses use the same immediate deduction on their state returns — would have cost the state roughly $288 million in reduced tax revenue. Lawmakers chose not to absorb that cost, at least not yet, which is the direct reason the bill is instead landing on the businesses that assumed the state would follow Washington's lead.

Who's Getting Hit Hardest

• Small and midsize companies with limited cash reserves, who don't have the balance sheet cushion to absorb a large unplanned state tax bill the way a bigger company can
• Biotech and medical device firms, which tend to carry unusually high R&D spending relative to revenue in their early years
• Software companies, where nearly all engineering payroll can qualify as R&D spending under the relevant tax definitions
• Defense contractors, architecture firms, and engineering firms with significant in-house research or design work
• Any business that already amended its 2022–2024 returns assuming Massachusetts would conform to the federal treatment, and now has to re-file

What the "Fix" Actually Does — and Doesn't Do

In June 2026, the Massachusetts legislature approved what's being described as a fix: a one-year delay pushing full conformity consideration to 2027. That's better than permanent decoupling, but it isn't relief for 2025 or 2026. It means the legislature is punting the decision, not making the deduction available now. If you're doing R&D in Massachusetts this year or next, you should plan on the five-year state amortization schedule applying to your state return regardless of what you're claiming federally, unless and until lawmakers actually vote to conform — which as of now remains an open question for 2027.

What to Do About It

• Don't assume state and federal treatment match. This is the core mistake that caught companies like Trivium off guard. Always confirm whether your state has conformed to a given federal tax change before you build financial plans around it — states routinely decouple from federal provisions that cost them revenue.
• Talk to your accountant about amended returns now. If you filed an amended Massachusetts return between 2022 and 2024 assuming immediate R&D expensing at the state level, find out whether you need to re-file using the five-year schedule before penalties or interest start accruing.
• Model both scenarios in your cash planning. Run your R&D spending through your profit and loss statement under both the federal (immediate expensing) and Massachusetts (five-year amortization) treatments so a state tax bill doesn't blindside your cash position the way it did for businesses that didn't see this coming.
• Revisit your reserves. If a chunk of what you assumed was a tax deduction is actually a multi-year amortization on your state return, it's worth checking whether your business bank account has enough cushion to cover a state liability you weren't planning for.

The Broader Lesson for Any Multi-State Business

Massachusetts isn't the only state grappling with whether to follow the federal government's lead on R&D expensing, and it won't be the last state to decouple from a federal tax change that carries a large price tag. Businesses that operate — or plan to operate — in more than one state should treat "does my state conform to this federal change" as a standing question any time Washington passes a significant tax law, rather than an assumption. The choice of entity structure matters here too: how R&D costs and related deductions flow through to owners can differ meaningfully depending on whether you're set up as an LLC or an S corp, which is worth revisiting with a tax professional if a chunk of your business is research-driven.

For now, the practical takeaway for Massachusetts businesses is straightforward even if the tax mechanics aren't: budget for the five-year amortization on your state return, keep an eye on whether the legislature actually conforms in 2027, and don't let a federal tax break turn into a state tax surprise the way it did for the companies already dealing with the bill.

Photo by Kelly Sikkema on Unsplash